Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma

In the present study, we found a survival benefit for metformin use in mRCC patients treated with sunitinib. Clinical and preclinical studies are warranted to validate our results and guide the use of metformin in the clinic.